The CGD Podcast

How does public heath surveillance work, and how can it be done better? Amanda Glassman tackles these questions with Dr. Oliver Morgan of the WHO and Dr. Theo Vos of the Institute for Health Metrics and Evaluation. Together, they examine the successes and limitations of public health surveillance during COVID-19; the infrastructure, incentives, and investments needed to strengthen capacity; and ways to ensure higher quality and more representative tracking of existing and emerging disease threats.

CGD's Masood Ahmed speaks with Rémy Rioux of Agence Française de Développement about the fifth annual Development Leaders Conference, the perfect storm of crises facing development agencies, and how new ways of thinking and financing can help them achieve their goals. 

On this episode of Pandemic Proof, Dr. Ayoade Alakija, the World Health Organization’s Special Envoy for the Access to COVID-19 Tools Accelerator (ACT-A) and co-chair of the African Union’s African Vaccine Delivery Alliance, joins Javier Guzman to discuss global cooperation during health emergencies. Together they reflect on the role of ACT-A in facilitating the development of and equitable access to medical countermeasures during the COVID-19 pandemic; highlight advantages and disadvantages of regional initiatives; and call for a truly representative global health system.

Countries in Latin America were hit especially hard by the COVID-19 pandemic. On this episode of Pandemic Proof, Amanda Glassman welcomes Dr. Jarbas Barbosa da Silva Jr., candidate for Director of the Pan American Health Organization (PAHO), to the podcast to discuss impacts and lessons learned. Together they reflect on the politicization of the public health response, the importance of health system surveillance, and the role of regional entities like PAHO and national regulatory agencies in vaccine regulation and rollout.

Dr. Boghuma Titanji, Assistant Professor of Medicine at the Emory University School of Medicine, joins Javier Guzman to reflect on the ongoing monkeypox outbreak and response. Together they discuss the parallels between monkeypox and previous infectious disease outbreaks such as COVID-19; inequities in access to vaccines and treatments; and the role national, regional, and international entities must play in preparedness and response to avoid making the same mistakes when the next—inevitable—pandemic hits. 

On this first episode of new CGD podcast series Pandemic Proof, co-hosts Amanda Glassman and Javier Guzman take stock of where things stand on the COVID-19 pandemic and discuss global priorities to strengthen capacity for pandemic preparedness and response. Victor Dzau, President of the National Academy of Medicine, then joins Amanda to discuss securing adequate investment and coordinating multilateral action to end the current pandemic and better prepare for and respond to the next infectious disease threat.

Get ready for Pandemic Proof, a new podcast from the Center for Global Development. Hosted by CGD's Amanda Glassman and Javier Guzman and featuring guests from around the world, Pandemic Proof confronts weaknesses in the global architecture for pandemic preparedness and response and explores policies and reforms that can better protect our world in the future. 

CGD's Megan O'Donnell speaks with coauthors Patience Marime-Ball (Women of the World Endowment) and Ruth Shaber (Tara Health Foundation) about the data backing the economic benefits of gender inclusivity, the work that went into creating their new book, and their recommendations for unlocking higher returns and lower risk.  

Gyude shares his takeaways from the first season, underlines the importance of elevating underrepresented ideas, and makes an announcement about Season 2.

CGD's Javier Guzman speaks with the Indian National Health Authority's Shankar Prinja about the structure and benefits of the PMJAY insurance scheme, the challenges of large-scale programs, and the need for researchers and policymakers to work together to produce and make use of evidence on what works.